Vilnip Tablet
Marketer
Lupin Ltd
Salt Composition
Vildagliptin (50mg)
Overview Vilnip Tablet
Diabetace Control Tablets are indicated for the management of type 2 diabetes. Optimal blood glucose control is achieved through combined use with a balanced diet and regular physical activity, thereby reducing the risk of serious diabetic complications such as vision impairment and renal dysfunction. Prescription of Diabetace Control Tablets is typically reserved for instances where dietary and exercise modifications, or other medications, prove insufficient to regulate blood sugar. It can be administered alone or in conjunction with other antidiabetic agents, with or without food, and the dosage will be individualized based on your health status and glucose readings. Adhere strictly to your physician's instructions regarding medication frequency and dosage. Consistent daily intake at the same time is crucial for optimal therapeutic outcomes. Discontinue use only under direct medical supervision. Maintaining the recommended diet and exercise regimen remains paramount throughout treatment. Lifestyle choices significantly influence diabetes management. Commonly reported adverse effects include hypoglycemia, tremors, headaches, dizziness, lethargy, and nausea. Recognizing hypoglycemic symptoms (including lightheadedness, sweating, dizziness, syncope, and xerostomia) and knowing appropriate countermeasures (e.g., consuming glucose tablets) is essential. Consult your doctor if side effects persist or are concerning. Prior to commencing treatment, inform your physician of any pre-existing conditions, including kidney disease, cardiovascular disease, or pancreatic disorders. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Interactions with other medications are possible; therefore, provide your physician with a comprehensive list of all concurrently used medications. Minimize alcohol consumption during treatment to mitigate the risk of hypoglycemia. Regular monitoring of renal function and blood glucose levels may be necessary to evaluate therapeutic efficacy.
Primary Ingredients of Vilnip Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vilnip Tablet
Managing type 2 diabetes
Major Benefits of Vilnip Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vilnip Tablet can be administered with or without food, though consistent timing is recommended.
Common Side effects of Vilnip Tablet:
- Hypoglycemia (low blood glucose level)
- Tremors
- Headache
- Dizziness
- Fatigue
- Nausea
How to use Vilnip Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Vilnip Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Vilnip Tablet works:
Vilnip tablets manage diabetes by stimulating insulin secretion from the pancreas and suppressing hyperglycemic hormones. This action consequently lowers both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vilnip Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Vilnip Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Vilnip Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Vilnip Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Vilnip Tablet is generally considered safe for individuals with kidney impairment; typically, no dosage alteration is needed. Nevertheless, patients experiencing moderate to severe kidney disease might require a modified dosage. Physician consultation is advised.
LiverUNSAFE
Individuals with hepatic impairment should likely abstain from Vilnip Tablet use; medical advice is recommended.
What if you forget to take Vilnip Tablet :
Should you forget to take a Vilnip Tablet, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Vilnip Tablet
| Label | Value |
|---|---|
| Chemical Category | Pyrrolidinecarbonitrile derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Dipeptidyl peptidase-4 inhibitors |



